Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12425690Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$1M
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#9,490
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing John David O'Neill as a PI. Multi-PI records show the full award amount for context.
- 5R44CA287881-03R44Multi-organ metastatic breast cancer cell-based assay platform that models organotropic metastases using patient organoids in human tissue-derived ECMs to accelerate anti-metastatic drug development$1Maward amount
Award organization
Organizations that administered FY2026 awards listing John David O'Neill as a PI.
FY2026 award administered by Xylyx Bio, Inc. (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardXylyx Bio, Inc.
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #2670
- 2025Entered Top 25% NationallyRanked #2670
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as John David O'Neill.